Piper Sandler analyst Patrick Moley raised the firm’s price target on CME Group (CME) to $250 from $240 and keeps an Overweight rating on the shares. The firm notes CME has seen the largest growth in consensus EPS estimates among U.S. exchanges this year, but no multiple expansion.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter